I find it amazing that Bigs is the greatest market timer in history when it comes to THOR and SSH. He was in THOR for it´s advance. He was out of SSH for it´s decline. He jumped out of THOR just before it´s huge drop and jumped back in #$%$ 8. Wow, this guy is UNBELEIVABLE. LITERALY!!
Bigsmarsta must be bigshorta judging from fis posts. SSH wil be huge even if it only addresses a third of the heart failure population. It's a big market. Just look at the competition in stents or pacemakers.
I have no position in SSH. I want to buy it. The only doubt I have is why there are no sales if the device was approved in europe last year. I'm speaking more to the competence of management than the value of the device. The device is obviously ingenious. It should be a billion dollar company. But... why no sales? I want someone to convince me so I can buy and be a long-term holder. I know it will probably go higher from here, and be very volatile, just because of day-traders. But I'm looking for a long-term investment. Help me out.
Sorry. I sent the last one before I was through. My question is: Since the device was approved in Europe LAST YEAR, why are there NO SALES???? Maybe someone could give me a satisfactory answer. I'd like to get in on the ground floor. This could be a $100 stock
I think you must be the one smoking crack. SSH has a product that will be approved and addresses a huge market. I may slip a littel on Monday, but this stock reminds of SRPT early on in it's run-up.
Actually, I went back to check on the last few weeks trading in SSH and nothing of the sort has occurred. Could you be a short that is trapped?
TJD over on MarketPulse is suggesting that SNTS is a short today at 24.45. Hmm, wasn't he the one who said that 24 was the line in the sand the other day whne we had the shakeout? We've rallied above that, and tested it this morning. Well, if he wants to short it, more power to him and anyone else who wants to take the risk.
Obviously there were a lot of stops between 24.10 (IBD's breakout point) and just below the 50 day ma. In fact, early this morning IBD reported that SNTS had declined 7% below it's buy point, a sell signsl acording to the rules. It seems as though this one-day shake-out cleared out all the sell-stops between those two points. If you notice on the one-minute chart, most of the sales (and there had to be buyers who stepped in at that point) ocurred right around the lows of the day, indicating support at that level. It also closed (within 4 cents) a small gap near 22. All in all, positive technical action.
Biotechs reporting earnings are smashing estimates today. The sector is hot and on the move. Should we expect less from SNTS with a great new product for ulceraitve colitis? Ulceris is probably seeing not only great sales but off-lable usage since it is so effective. Will it wait for earnings or take off with the rest of the sector? Today was a successful test of the 50 day ma. Only 2 points away from an all-time high.
TraderJohnDoe over on Market Pulse says the SNTS finished badly today and that the bulls must be squirming???? They way I see it, all the stops just below the 50 day ma were cleared out today and the stock recaptured almost all of the loss. As IBD would say it bounced strongly off of it's 50 day moving average. Today was deffinitely a shake-out.
Some joker named TraderJohnDoe has filled the Market Pulse with bearish meesages about SNTS looking for 9 points to the downside. He must be short, and a little insecure, judging from all the messages he posted.
Luke, I think your wholistic ideology, while correct, is getting in the way of evalutaing this stock the way the market values these types of stocks. Big pharma is in controll of the health system and there's no way to change that. There's just too much money involved.
So. What matters it what's happening now, not yesterday. I've seen delayed reactions in stocks before. Especially if there is no other "news" in another small biotech today. It could be "the only game in town". We'll see.
Phase 2 has been completed. Read TTHI's statement!!!
An extensive clinical program of Phase 1 and Phase 2 studies have been completed with ELND005 to support clinical development, including the recently published Phase 2 study ELND005-AD201 in AD. ELND005 is also being studied as a maintenance treatment of Bipolar Disease in an ongoing study (Study ELND005-BPD201).
HALO has a product, backed by Roche, that is ready for approval in Europe. Market cap is $1 billion. If we waited until TTHI gets close to approval then the stock price will be 10 time what it is today. I just don't see a lot of downside with this stock. $3 or $4 for two drugs with major backing of big pharmas is cheap.
TTHI has a market cap of $80 million. ACAD has a market cap of $1.6 billion. TTHI has 2 drugs in phase 2. ACAD has a drug in phase 3. I like TTHI's odds. Both Lilly and Elan have backed TTHI. Not sure who's backing ACAD.